#USA #healthcare #Madison #Accuray #Radiation Therapy

Accuray's Participation in Jefferies Global Healthcare Conference 2025

Madison, Wisconsin - Accuray Incorporated (NASDAQ: ARAY) is set to take the stage at the Jefferies Global Healthcare Conference 2025. Scheduled for June 4, 2025, at 5:30 PM EDT, the management team will engage in a fireside chat, discussing the company's latest advancements and commitment to transforming patient care through innovative radiation therapy solutions.

The event promises to be a significant platform for fostering dialogue about the future of healthcare technology, particularly in relation to oncology and neuro-radiosurgery. Accuray is dedicated to enhancing the effectiveness of radiation treatments, which is evident in its wide-ranging solutions aimed at addressing the diverse needs of patients.

Attendees and interested parties can tune into the discussion via a live webcast available on the Accuray investor relations page at investors.accuray.com. For those unable to attend, the call will be made accessible as a replay for a period of 90 days following the event. This feature underlines Accuray's commitment to transparency and accessibility, ensuring that stakeholders stay informed about the company’s progress and innovations.

About Accuray

Accuray has steadfastly focused on revolutionizing radiation therapy to significantly improve the lives of patients battling cancer and other complex conditions. With its headquarters in Madison, Wisconsin, Accuray has established a global presence, working closely with clinicians and healthcare administrators. The company’s mission is to continually innovate in the field of radiation therapy, adapting to the evolving needs of the healthcare landscape.

Some of the advanced technologies Accuray has innovated include the CyberKnife® system, designed to provide precise radiation treatment and enhance the ease of administration for complex cases. Their focus on patient-centered care drives their efforts to develop treatments that are not only effective but also minimize recovery times, allowing patients to resume their everyday lives more swiftly.

Accuray actively partners with healthcare professionals to ensure that their solutions meet the highest standards of efficacy and safety. The collaborative efforts aim to address a broad spectrum of patient needs, positioning Accuray at the forefront of cancer treatment solutions.

For more information about Accuray’s innovations and to learn more about their participation in upcoming conferences, visit their website at www.accuray.com and follow them on social media channels including Facebook, LinkedIn, X, and YouTube.

Conclusion

Accuray's participation in the Jefferies Global Healthcare Conference 2025 is not just an opportunity for the company to showcase its advancements but also serves as a platform for broader discussions on the future of radiation therapy and patient care. As it continues to push the boundaries of what's possible in medical technology, Accuray remains committed to making a profound difference in the lives of patients around the world.